Dember Laura M, Archdeacon Patrick, Krishnan Mahesh, Lacson Eduardo, Ling Shari M, Roy-Chaudhury Prabir, Smith Kimberly A, Flessner Michael F
Renal, Electrolyte and Hypertension Division and Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania;
Office of Medical Policy and Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
J Am Soc Nephrol. 2016 Oct;27(10):2955-2963. doi: 10.1681/ASN.2016030340. Epub 2016 Jul 11.
Pragmatic clinical trials are conducted under the real-world conditions of clinical care delivery. As a result, these trials yield findings that are highly generalizable to the nonresearch setting, identify interventions that are readily translatable into clinical practice, and cost less than trials that require extensive research infrastructures. Maintenance dialysis is a setting especially well suited for pragmatic trials because of inherently frequent and predictable patient encounters, highly granular and uniform data collection, use of electronic data systems, and delivery of care by a small number of provider organizations to approximately 90% of patients nationally. Recognizing the potential for pragmatic trials to generate much needed evidence to guide the care of patients receiving maintenance dialysis, the Kidney Health Initiative assembled a group of individuals with relevant expertise from academia, industry, and government to provide the nephrology community with information about the design and conduct of such trials, with a specific focus on the dialysis setting. Here, we review this information, and where applicable, use experience from the ongoing Time to Reduce Mortality in End Stage Renal Disease Trial, a large cluster-randomized, pragmatic trial evaluating hemodialysis session duration, to illustrate challenges and solutions to operational, ethical, and regulatory issues.
实用性临床试验是在临床护理提供的真实世界条件下进行的。因此,这些试验产生的结果在非研究环境中具有很高的普遍性,能够识别易于转化为临床实践的干预措施,并且成本低于需要广泛研究基础设施的试验。维持性透析是一个特别适合进行实用性试验的环境,因为患者就诊频率高且可预测,数据收集高度细化且统一,使用电子数据系统,并且全国约90%的患者由少数几个医疗机构提供护理。认识到实用性试验有可能产生急需的证据来指导维持性透析患者的护理,肾脏健康倡议组织召集了一群来自学术界、行业和政府的相关专家,为肾脏病学界提供有关此类试验设计和实施的信息,特别关注透析环境。在此,我们回顾这些信息,并在适用的情况下,利用正在进行的“降低终末期肾病死亡率时机”试验的经验,该试验是一项大型整群随机实用性试验,评估血液透析疗程时长,以说明操作、伦理和监管问题的挑战及解决方案。